Magnus Thörn

2.9k citations
59 papers · 2.2k indexed · h-index 30
Topics
Cutaneous Melanoma Detection and Management (15 papers)Bladder and Urothelial Cancer Treatments (10 papers)Cancer Immunotherapy and Biomarkers (9 papers)

In The Last Decade

Magnus Thörn

58 papers receiving 2.1k citations

Peers

Magnus Thörn
Comparison fields: 5 of 103
  • Oncology 993
  • Surgery 552
  • Dermatology 492
  • Immunology 466
  • Epidemiology 407
Replace Anne Østerlind with:
Anne Østerlind Denmark
Ashley A. Fletcher United Kingdom
Bernt Lindelöf Sweden
Aroldo Rizzo Italy
H. Søgaard Denmark
R. L. Barnhill United States
V.R. Doherty United Kingdom
Elena Netchiporouk Canada
Geraldine P. Schechter United States
Tomonori Ishii Japan
Magnus Thörn relative to Anne Østerlind Denmark Anne Østerlind's profile →
Citations per field
00.5×3.1×
Anne Østerlind · 1×
Citations per year

Countries citing papers authored by Magnus Thörn

Since Specialization
Citations

This map shows the geographic impact of Magnus Thörn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magnus Thörn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magnus Thörn more than expected).

Fields of papers citing papers by Magnus Thörn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Magnus Thörn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magnus Thörn. The network helps show where Magnus Thörn may publish in the future.

Co-authorship network of co-authors of Magnus Thörn

This figure shows the co-authorship network connecting the top 25 collaborators of Magnus Thörn. A scholar is included among the top collaborators of Magnus Thörn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Magnus Thörn. Magnus Thörn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 7
2 17
3 51
4 10
5 13
6 69
7 23
8 39
9 257
10 17
11 63
12 53
13 44
14 25
15 12
16 47
17 2
18 18
19 9
20 105

About Magnus Thörn

Magnus Thörn is a scholar working on Oncology, Immunology and Immunology and Allergy, having authored 59 papers that have together received 2.2k indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (15 papers), Bladder and Urothelial Cancer Treatments (10 papers) and Cancer Immunotherapy and Biomarkers (9 papers). The work is most often cited by research in Dermatology (492 citations), Oncology (993 citations) and Immunology (466 citations). Magnus Thörn has collaborated with scholars based in Sweden, United States and New Zealand. Frequent co-authors include Hans‐Olov Adami, Ola Winqvist, Per Marits, Pär Sparén, Ulrik Ringborg, R. Bergström, Amir Sherif, Reinhold Bergström, Peter Janson and Yngve Raab. Their work appears in journals such as The Journal of Immunology, PLoS ONE and JNCI Journal of the National Cancer Institute.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026